Trump, Marty Makary and FDA

Johns Hopkins’ Marty Makary, Trump’s choice for FDA, a ‘brilliant surgeon’ with some ‘worrisome’ views
Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug Administration — Dr. Marty Makary, a Johns Hopkins researcher, surgeon and author — as a “courageous leader” and a “reasonable choice,” who nevertheless espouses some “worrisome” views.
Trump picks Marty Makary to lead FDA, Dave Weldon to run CDC
Makary and Weldon, who have criticized the agencies they may soon run, were joined by Janette Nesheiwat, Trump’s pick to be surgeon general.
Trump nominates Marty Makary, who opposed COVID vaccine mandates, to head FDA
President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration.
Who is Dr. Marty Makary, Trump’s pick to head the FDA?
The nominee, a surgeon at Johns Hopkins, has criticized the use of pesticides on food and the industry turning against “natural fat.”
Trump picks Dr. Marty Makary as Food and Drug Administration commissioner
President-elect Trump announced on Friday that he is nominating Dr. Marty Makary, a Johns Hopkins School of Medicine professor, to head the Food and Drug Administration.
Trump picks Dr. Marty Makary, a Johns Hopkins surgeon, for FDA chief
President-elect Donald Trump on Friday nominated Dr. Marty Makary, a pancreatic surgeon at Johns Hopkins University, as commissioner of the FDA.
Trump to nominate Marty Makary to lead FDA
President-elect Donald Trump has selected Marty Makary, a Johns Hopkins surgeon who criticized the Biden administration’s Covid response, to lead the FDA. “FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator,” Trump said in a statement late Friday, adding Makary would “course-correct” the agency if confirmed.
Trump Nominates Marty Makary For FDA Commissioner
Makary, a vocal critic of the federal government’s response to Covid-19, would oversee the federal agency charged with approving all new drugs.
Hims & Hers Shares Jump as Trump FDA Pick Seen as Major Ally
Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a major beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration.
Hims & Hers jumps after Trump nominates Dr. Marty Makary for FDA
Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns
Healthy Returns: Trump's FDA pick Makary may be a relief for biotech and pharma, analysts say
Trump’s FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink approved for new studies, company says.
Makary for FDA. Here’s what you need to know.
President-elect Donald Trump’s Friday night news dump of health care nominees included the expected naming of Dr. Marty ...
STAT5d
‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner
STAT reporters reached out to key figures in biotech, pharma, and medical devices to find out what they think about President ...